Mesoblast Non Currrent Assets Other Over Time

MESO Stock  USD 11.20  0.36  3.32%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Mesoblast Performance and Mesoblast Correlation.
To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.
  
As of the 11th of December 2024, Non Currrent Assets Other is likely to grow to about 2.2 M.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesoblast. If investors know Mesoblast will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesoblast listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.05)
Revenue Per Share
0.06
Quarterly Revenue Growth
(0.41)
Return On Assets
(0.05)
Return On Equity
(0.18)
The market value of Mesoblast is measured differently than its book value, which is the value of Mesoblast that is recorded on the company's balance sheet. Investors also form their own opinion of Mesoblast's value that differs from its market value or its book value, called intrinsic value, which is Mesoblast's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesoblast's market value can be influenced by many factors that don't directly affect Mesoblast's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesoblast's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesoblast is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesoblast's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Non Currrent Assets Other Analysis

Compare Mesoblast and related stocks such as Virios Therapeutics Llc, Aditxt Inc, and Lipocine Non Currrent Assets Other Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle
201020112012201320142015201620172018201920202021202220232024
ADTX119.4 K119.4 K119.4 K119.4 K119.4 K119.4 K119.4 K119.4 K119.4 K119.4 K72.3 K668.8 K405.4 K11.3 M11.8 M
LPCN(11.6 M)(11.6 M)(11.6 M)(11.6 M)(20.9 M)23.8 K30.8 K30.8 K23.8 K23.8 K23.8 K4.1 M(42.6 M)23.8 K24.9 K
CNTB6.4 M6.4 M6.4 M6.4 M6.4 M6.4 M6.4 M6.4 M6.4 M6.4 M1.6 MM34.6 K132 K125.4 K
ABOS144 K144 K144 K144 K144 K144 K144 K144 K144 K144 K14 K14 K151 K454 K476.7 K
ETON32 K32 K32 K32 K32 K32 K32 K32 K52 K61 K40 K21 K12 K10.8 K10.3 K
NUVB421 K421 K421 K421 K421 K421 K421 K421 K421 K421 K421 K421 K559.5 M728 K691.6 K
ELDN20 K20 K20 K80 K200 K45 K120 K869 K869 K639 K383 K400 K150 K186 K309.2 K
FENC(1.0)0.00.00.00.00.00.00.00.0262 K27 K27 K211 KK5.7 K
LRMR242 K242 K242 K242 K242 K94 K61 K57 K57 K90 K419 K669 K638 K659 K692 K
VRCA0.00.00.00.00.00.00.00.01.8 M830 K3.7 M295 K276 K452 K429.4 K
XFOR363 K363 K363 K363 K363 K363 K1.4 M1.3 M639 K1.9 M3.3 M1.7 M1.2 M1.4 M1.6 M
INZY34 K34 K34 K34 K34 K34 K34 K34 K34 K56 K3.5 M3.4 M3.8 MM2.4 M
TERN335 K335 K335 K335 K335 K335 K335 K335 K335 K719 K246 K94 K37 K56 K53.2 K
DAWN107 K107 K107 K107 K107 K107 K107 K107 K107 K107 K107 K169 K469 K214 K263.7 K
HOOK199 K199 K199 K199 K199 K199 K199 K199 K1.6 M1.1 M1.9 M1.4 M863 KM1.3 M
FBIO349 K349 K349 K104 K14.7 M14.8 M16.3 M18 M16.4 M17.7 M2.7 M3.4 M3.7 M6.7 M7.6 M
MBIO0.00.00.00.00.00.00.0751 K771 K250 K250 K362 K261 K833 K478.2 K
ACHL34 K34 K34 K34 K34 K34 K34 K34 K34 K34 KM3.5 MM2.2 M2.6 M
APTO(68.7 K)0.0(76.85)(76.85)(76.85)212 K212 K(1.0)(142)(94.0)(48.0)465 K1.3 M1.2 M1.2 M

Mesoblast and related stocks such as Virios Therapeutics Llc, Aditxt Inc, and Lipocine Non Currrent Assets Other description

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

My Equities

My Current Equities and Potential Positions

Mesoblast
MESO
ClassificationCancer Fighters
LocationAustralia
ExchangeNASDAQ Exchange
USD 11.2
When determining whether Mesoblast offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesoblast's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesoblast Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesoblast Stock:
Check out Mesoblast Performance and Mesoblast Correlation.
To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Mesoblast technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Mesoblast technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Mesoblast trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...